OtoNexus Medical Technologies Stock

OtoNexus Medical Technologies commercializes a patented medical device designed to diagnose middle ear infections.

Sign up today and learn more about OtoNexus Medical Technologies Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About OtoNexus Medical Technologies Stock

OtoNexus Medical Technologies commercializes a patented medical device designed to diagnose middle ear infections in children and adults. It will allow clinicians to accurately identify viral vs. bacterial infection and determine whether an antibiotic is appropriate. The device applies a well-known medical technology, ultrasound, in a completely novel way to achieve a key advance in the detection of otitis media. One-use-per-patient tips create a recurring revenue stream. The device will provide data in seconds and will be easy to use by physicians or non-physician personnel (NPs, PAs).

Funding History

June 2015$3.0M
November 2015$2.2M
July 2017$225K
December 2017$5.5M
July 2018$2.5M
March 2019$718K
September 2019$5.0M

Management

Chief Executive Officer, Co-Founder

Caitlin Cameron

Co-Founder and Chief Science Officer

Mark A. Moehring

Founder & Chief Medical Officer

George A. Gates

Chief Technology Officer

John Alleman

Chief Product Officer

Gina Kelly

Vice President Product Development

Mehdi Badr

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo